Search

Displaying results 8561 - 8570 of 10000 in total
  1. Drug

    Flumatinib

    go.drugbank.com/drugs/DB11904
    Investigational

    Flumatinib has been used in trials studying the treatment of Myelogenous Leukemia, Chronic.

  2. Drug

    OBP-801

    go.drugbank.com/drugs/DB12279
    Investigational

    OBP-801 has been used in trials studying the treatment of Solid Tumor.

  3. Drug

    Verucerfont

    go.drugbank.com/drugs/DB12512
    Investigational

    Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia.

  4. Drug

    Tedatioxetine

    go.drugbank.com/drugs/DB12641
    Investigational

    Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.

  5. Drug

    Olumacostat glasaretil

    go.drugbank.com/drugs/DB12642
    Investigational

    Olumacostat glasaretil has been used in trials studying the treatment of Acne Vulgaris.

  6. Drug

    Ozagrel

    go.drugbank.com/drugs/DB12017
    Investigational

    Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

  7. Drug

    Beclabuvir

    go.drugbank.com/drugs/DB12225
    Investigational

    Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

  8. Drug

    Sovleplenib

    go.drugbank.com/drugs/DB17557
    Investigational

    It is under investigation in clinical trial NCT03483948 (Phase I Study of Hmpl-523+azacitidine in Elderly Patients With Acute Myeloid Leukemia).

  9. Drug

    Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-

    go.drugbank.com/drugs/DB16204
    Investigational

    the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis). … Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for

  10. Drug

    Alpibectir

    go.drugbank.com/drugs/DB21561
    Investigational

    Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).